Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection

Oliver Y.‐P Hu, Edward Gfeller, John H. Perrin, Stephen H. Curry

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)

摘要

The stability, partition coefficient, plasma protein binding, red blood cell distribution, and whole blood concentrations of trimeprazine were investigated. Trimeprazine solution was stable for 6 months at −20 °C and 3.5 months at 40 °C. In whole blood trimeprazine was stable for 5 weeks at −20 °C., 24 h at 4 °C., 4h at 25 °C and 1 h at 37 °C. The apparent hexane‐water partition coefficient varied from 1.50 (at pH 4.83) to over 100 (at pH 10.54). The fraction bound to plasmaprotein exceeded 0.9 as estimated by equilibrium dialysis with correction for volume shift. The mean plasma/red blood cell concentration ratio was 1.17 and the mean red blood cell/plasma distribution coefficient was 8.65. Six healthy adult males received single 5 mg doses of trimeprazine in a syrup (5 mg in 10 ml) and tablets with at least two weeks between doses. Blood was collected for 48 h. The mean (±s.e.m.) times for peak blood concentrations were 3.5 ± 0.22 h for the syrup and 4.5 ± 0.43 h for the tablets. There were no significant differences in Cmax values. The overall mean (±s.e.m.) terminal phase half‐life was 4.78 ± 0.59 h. Mean (±s.e.m.) areas under the concentration time curves from 0 to infinity (AUC∞) were 11.0 ± 1.99 ng h−1 ml−1 and 7.67 ± 1.05 ng h−1 ml−1 for syrup and tablets, respectively. The mean relative bioavailability for the tablets was approximately 70% with respect to the syrup.
原文英語
頁(從 - 到)172-176
頁數5
期刊Journal of Pharmacy and Pharmacology
38
發行號3
DOIs
出版狀態已發佈 - 一月 1 1986
對外發佈

ASJC Scopus subject areas

  • 藥理
  • 藥學科學

指紋

深入研究「Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection」主題。共同形成了獨特的指紋。

引用此